OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+4.63%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$104M
AUM Growth
+$104M
(-3.4%)
Cap. Flow
-$5.88M
Cap. Flow
% of AUM
-5.68%
Top 10 Holdings %
Top 10 Hldgs %
55.77%
Holding
60
New
9
Increased
3
Reduced
31
Closed
17
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$23M |
| 2 |
iShares Biotechnology ETF
IBB
|
$4.55M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$3.18M |
| 4 |
GSK
GSK
|
$2.17M |
| 5 |
IQVIA
IQV
|
$1.41M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.3M |
| 2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$2.64M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$2.3M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$1.88M |
| 5 |
Pacira BioSciences
PCRX
|
$1.86M |
Sector Composition
| 1 | Healthcare | 62.03% |
| 2 | Real Estate | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Pacira BioSciences
PCRX
$1.2B
| – | – |
-35,110
| Closed | -$1.86M |
|
52
Vericel Corp
VCEL
$1.83B
| – | – |
-298,941
| Closed | -$1.75M |
|
|
CLVS
53
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-75,000
| Closed | -$1.44M |
|
|
EPZM
54
DELISTED
Epizyme, Inc
EPZM
| – | – |
-189,564
| Closed | -$2.3M |
|
|
DRNA
55
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-108,000
| Closed | -$579K |
|
|
ACHN
56
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – |
-99,000
| Closed | -$764K |
|
|
LOXO
57
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-36,000
| Closed | -$984K |
|
|
RXDX
58
DELISTED
Ignyta, Inc.
RXDX
| – | – |
-81,000
| Closed | -$548K |
|
|
MACK
59
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – |
-90,000
| Closed | -$753K |
|
|
ZGNX
60
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-68,130
| Closed | -$630K |
|